A5009114082- Diabetes Treatment and Management
- Diabetes Management and Research
- Pancreatic function and diabetes
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Metabolism, Diabetes, and Cancer
- Pituitary Gland Disorders and Treatments
- Pharmacology and Obesity Treatment
- Atrial Fibrillation Management and Outcomes
- Diet and metabolism studies
- COVID-19 Clinical Research Studies
- Head and Neck Anomalies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pancreatitis Pathology and Treatment
- Adrenal and Paraganglionic Tumors
- Bone and Joint Diseases
- Hormonal Regulation and Hypertension
- Phytochemicals and Antioxidant Activities
- Pain Management and Treatment
- Natural Antidiabetic Agents Studies
- Sarcoidosis and Beryllium Toxicity Research
- Vitamin D Research Studies
- Tea Polyphenols and Effects
University of Maryland, Baltimore
2016-2025
University of Maryland Medical Center
2015-2024
University of Maryland Medical Center Midtown Campus
2022-2023
Albert Einstein College of Medicine
2022
Virginia Commonwealth University
2021
Hualien Tzu Chi Medical Center
2021
Medical University of South Carolina
2020
University of Alabama at Birmingham
2020
University of Baltimore
2019-2020
Indianapolis Zoo
2019
Advances in continuous glucose monitoring (CGM) have transformed ambulatory diabetes management. Until recently, inpatient use of CGM has remained investigational, with limited data on its accuracy the hospital setting.To analyze Dexcom G6, we compared retrospective matched-pair and capillary point-of-care (POC) from three studies (two interventional one observational) general medicine surgery patients treated insulin. Analysis metrics included mean absolute relative difference (MARD),...
The efficacy and safety of continuous glucose monitoring (CGM) in adjusting inpatient insulin therapy have not been evaluated.This randomized trial included 185 general medicine surgery patients with type 1 2 diabetes treated a basal-bolus regimen. All subjects underwent point-of-care (POC) capillary testing before meals bedtime. Patients the standard care (POC group) wore blinded Dexcom G6 CGM dose adjusted based on POC results, while group, adjustment was daily profile. Primary end points...
Abstract Context Concomitant obesity is common among patients with type 1 diabetes mellitus (T1DM), yet adjunctive therapy options are scarce. Objective We assess the efficacy and adverse outcomes of glucagon-like peptide (GLP-1) analogues when used as for T1DM. Method PubMed, EMBASE, Cochrane Central, Scopus databases were searched randomized controlled trials up to December 2022. Efficacy A1c level, body weight, total daily insulin (TDI) after ≥12 weeks GLP-1 therapy. also assessed 12...
Abstract Background Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs) can potentially suppress the progression of cardiac fibrosis ischemic cardiomyopathy. Whether different influence risk HF older adults AF DM unknown. This study aimed to evaluate who were administered NOACs or warfarin. Methods A nationwide retrospective...
Evidence about the association between types of oral anticoagulants and hazards diabetes complications is limited in patients with atrial fibrillation (AF) mellitus (DM).To compare mortality AF DM receiving non-vitamin K antagonist (NOACs) those warfarin.A retrospective cohort study.Nationwide data obtained from Taiwan's National Health Insurance Research Database.Patients NOACs or warfarin 2012 2017 Taiwan were enrolled. Treatment groups determined by patients' first initiation...
Background/ObjectiveOur objective is to highlight the importance of identifying symptoms SREAT, especially in setting intermittent cognitive dysfunction, and inform that SREAT can develop even patients with a history partial thyroidectomies.Case ReportWe present case 51-year-old female long-standing hypothyroidism presenting acute onset myoclonus, involuntary tremors, fatigue, malaise, palpitations for two weeks, lapses function. The patient’s workup completely within normal limits including...
Abstract Aims Evidence regarding the risks of serious hypoglycaemia for patients with atrial fibrillation (AF) and diabetes mellitus (DM) taking antidiabetic medications concurrent non-vitamin K antagonist oral anticoagulants (NOACs) vs. warfarin is limited. This study aimed to investigate this knowledge gap. Methods results retrospective cohort used nationwide data from Taiwan's National Health Insurance Research Database included a total 56 774 adult treated between 1 January 2012 31...
To compare the risk of diabetes development in patients with atrial fibrillation (AF) treated non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin.We conducted a nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database. Adult new onset AF, NOACs or warfarin between 2012 2016, were included. The NOAC was further divided into dabigatran, rivaroxaban apixaban groups. primary outcome incident requiring treatment antidiabetic drugs. Fine Gray...
We explored whether the anti-prostate cancer (PC) activity of androgen receptor-axis-targeted agents (ARATs) abiraterone and enzalutamide is enhanced by metformin. Using complementary biological molecular approaches, we determined associated underlying mechanisms in pre-clinical androgen-sensitive PC models. ARATs increased androgren receptors (ARs) LNCaP AR/ARv7 (AR variant) VCaP cells, inhibited cell proliferation both, induced poly(ADP-ribose) polymerase-1 (PARP-1) cleavage death but not...